» Articles » PMID: 30279396

Resolving Digital Staphylococcal Osteomyelitis Using Bacteriophage-A Case Report

Overview
Specialty Pharmacology
Date 2018 Oct 4
PMID 30279396
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Infections involving diabetic foot ulcers (DFU) are a major public health problem and have a substantial negative impact on patient outcomes. Osteomyelitis in an ulcerated foot substantially increases the difficulty of successful treatment. While literature suggests that osteomyelitis in selected patients can sometimes be treated conservatively, with no, or minimal removal of bone, we do not yet have clear treatment guidelines and the standard treatment failure fallback remains amputation. The authors report on the successful treatment, with a long term follow up, of a 63 YO diabetic female with distal phalangeal osteomyelitis using bacteriophage, a form of treatment offering the potential for improved outcomes in this era of escalating antibiotic resistance and the increasingly recognized harms associated with antibiotic therapy.

Citing Articles

Antibiotic Resistance of Strains-Searching for New Antimicrobial Agents-Review.

Michalik M, Podbielska-Kubera A, Dmowska-Koroblewska A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861144 PMC: 11768290. DOI: 10.3390/ph18010081.


Phage Therapy Against Antibiotic-Resistant and Multidrug-Resistant Infections Involving Nonhealing Wounds and Prosthetic Joint Infections Associated With Biofilms: A Mini-Review.

Haq K, Figgitt M, Lee D Can J Infect Dis Med Microbiol. 2024; 2024:6252415.

PMID: 39545100 PMC: 11563716. DOI: 10.1155/2024/6252415.


Bacteriophage entrapment strategies for the treatment of chronic wound infections: a comprehensive review.

Mohan N, Bosco K, Peter A, Abhitha K, Bhat S Arch Microbiol. 2024; 206(11):443.

PMID: 39443305 DOI: 10.1007/s00203-024-04168-0.


Current status of clinical trials for phage therapy.

Uchechukwu C, Shonekan A J Med Microbiol. 2024; 73(9).

PMID: 39320361 PMC: 11423923. DOI: 10.1099/jmm.0.001895.


Advances in the targeted theragnostics of osteomyelitis caused by Staphylococcus aureus.

Abdulrehman T, Qadri S, Haik Y, Sultan A, Skariah S, Kumar S Arch Microbiol. 2024; 206(7):288.

PMID: 38834761 DOI: 10.1007/s00203-024-04015-2.


References
1.
Atkins B, Gottlieb T . Fusidic acid in bone and joint infections. Int J Antimicrob Agents. 1999; 12 Suppl 2:S79-93. DOI: 10.1016/s0924-8579(98)00077-6. View

2.
Levin M . Management of the diabetic foot: preventing amputation. South Med J. 2002; 95(1):10-20. View

3.
Shirtliff M, Calhoun J, Mader J . Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clin Orthop Relat Res. 2002; (401):239-47. DOI: 10.1097/00003086-200208000-00027. View

4.
Beardmore A, Brooks D, Wenke J, Thomas D . Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute. J Bone Joint Surg Am. 2005; 87(1):107-12. DOI: 10.2106/JBJS.C.01670. View

5.
Brin Y, Golenser J, Mizrahi B, Maoz G, Domb A, Peddada S . Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin. J Control Release. 2008; 131(2):121-7. PMC: 2755290. DOI: 10.1016/j.jconrel.2008.07.022. View